VP
Vanda Pharmaceuticals Inc
🇩🇪XSTU.VM4GermanyHealthcare
€4.29EURup +0.01 (+0.23%)ClosedEnd of day5:18 AM
Price€4.29+0.01 (+0.23%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US9216591084
- CUSIP
- Not reported
Company
- Employees
- 533
- Headquarters
- Washington, United States
- Website
- https://www.vandapharma.com
- CEO
- Dr. Mihael H. Polymeropoulos M.D.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- -$4.56
- P/E LTM
- -1.34
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $215.72M+6.02%up year on year
- Net income
- -$274.85M-310.61%down year on year
- Gross margin
- 92.82%-0.77%down year on year
- Free cash flow
- -$193.44M-193.51%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.